Potential and Opportunities for Use of Recombinant Lactic Acid Bacteria in Human Health

作者: Sean Hanniffy , Ursula Wiedermann , Andreas Repa , Annick Mercenier , Catherine Daniel

DOI: 10.1016/S0065-2164(04)56001-X

关键词:

摘要: Publisher Summary This chapter discusses the potential and future opportunities for use of recombinant lactic acid bacteria in human health. It is now clear that sufficient advances genetics (LAB) have made it possible to construct safe LAB-based vaccines are capable eliciting protection against lethal challenge with toxin or a pathogen relevant disease model. There also enhance efficacy LAB through increased antigen expression combined delivery multiple immunogens specific adjuvants. Further insights may be gained direct comparisons strains different persistence survival characteristics immunostimulatory properties immunization routes schedules selected target disease. Genetic engineering clearly has further optimize LAB, define optimal placement dosage regimes clinical settings, their ability deliver pharmaceutical protein.

参考文章(311)
Corinne Grangette, Heide Müller-Alouf, Marie-Claude Geoffroy, Denise Goudercourt, Mireille Turneer, Annick Mercenier, Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence. Vaccine. ,vol. 20, pp. 3304- 3309 ,(2002) , 10.1016/S0264-410X(02)00301-8
I Kato, K Tanaka, T Yokokura, Lactic acid bacterium potently induces the production of interleukin-12 and interferon-γ by mouse splenocytes International Journal of Immunopharmacology. ,vol. 21, pp. 121- 131 ,(1999) , 10.1016/S0192-0561(98)00072-1
Alain Guillot, Christophe Gitton, Patricia Anglade, Michel-Yves Mistou, Proteomic analysis of Lactococcus lactis, a lactic acid bacterium PROTEOMICS. ,vol. 3, pp. 337- 354 ,(2003) , 10.1002/PMIC.200390047
F. Lamine, J. Fioramonti, L. Bueno, F. Nepveu, E. Cauquil, I. Lobysheva, H. Eutamène, V. Théodorou, Nitric oxide released by Lactobacillus farciminis improves TNBS-induced colitis in rats. Scandinavian Journal of Gastroenterology. ,vol. 39, pp. 37- 45 ,(2004) , 10.1080/00365520310007152
Isabelle Boucher, Marc Parrot, Hélène Gaudreau, Claude P. Champagne, Christian Vadeboncoeur, Sylvain Moineau, Novel food-grade plasmid vector based on melibiose fermentation for the genetic engineering of Lactococcus lactis. Applied and Environmental Microbiology. ,vol. 68, pp. 6152- 6161 ,(2002) , 10.1128/AEM.68.12.6152-6161.2002
D. A. Israel, N. Salama, U. Krishna, U. M. Rieger, J. C. Atherton, S. Falkow, R. M. Peek, Helicobacter pylori genetic diversity within the gastric niche of a single human host Proceedings of the National Academy of Sciences of the United States of America. ,vol. 98, pp. 14625- 14630 ,(2001) , 10.1073/PNAS.251551698
C.B.M Maassen, J.D Laman, M.J Heijne den Bak-Glashouwer, F.J Tielen, J.C.P.A van Holten-Neelen, L Hoogteijling, C Antonissen, R.J Leer, P.H Pouwels, W.J.A Boersma, D.M Shaw, Instruments for oral disease-intervention strategies: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis Vaccine. ,vol. 17, pp. 2117- 2128 ,(1999) , 10.1016/S0264-410X(99)00010-9
Quan Shu, Hai Lin, Kay J. Rutherfurd, Stan G. Fenwick, Jaya Prasad, Pramod K. Gopal, Harsharnjit S. Gill, Dietary Bifidobacterium lactis (HN019) enhances resistance to oral Salmonella typhimurium infection in mice. Microbiology and Immunology. ,vol. 44, pp. 213- 222 ,(2000) , 10.1111/J.1348-0421.2000.TB02486.X